We considered that the abnormal expression of those regulators and genes may be potential predictor of the risk of MI recurrence, and the original paper also confirmed that the abnormal expression of the DAB2 influence the severity of AMI through disruption of cholesterol transport10. This evidence concerns the gene DAB2 and myocardial infarction.